Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2000
03/30/2000WO2000017369A2 Alzheimer's disease secretase
03/30/2000WO2000017368A1 Orange fruit pectinacetylesterase
03/30/2000WO2000017367A1 Aspergillus tubigensis polygalacturonase
03/30/2000WO2000017366A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
03/30/2000WO2000017365A2 Binary viral expression system in plants
03/30/2000WO2000017364A2 Cyclin d polynucleotides, polypeptides and uses thereof
03/30/2000WO2000017363A2 Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
03/30/2000WO2000017362A1 Human interleukin-b50, therapeutic uses
03/30/2000WO2000017361A2 Interferon-epsilon
03/30/2000WO2000017360A1 Cystine knot growth factor mutants
03/30/2000WO2000017359A1 Novel cartilage-associated polynucleotides, polypeptides encoded thereby, and uses thereof
03/30/2000WO2000017358A2 Human chaperone proteins
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017356A2 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
03/30/2000WO2000017355A2 Human cytoskeleton associated proteins
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017353A1 Ucp4
03/30/2000WO2000017352A1 Plants capable of metabolizing drugs and utilization thereof
03/30/2000WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
03/30/2000WO2000017350A1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
03/30/2000WO2000017349A1 A HUMAN Hsg III GENE
03/30/2000WO2000017348A1 G protein-coupled receptor agonists or antagonists
03/30/2000WO2000017347A1 Camelid sex specific polynucleotide sequences
03/30/2000WO2000017346A2 Hairpin hybridizer molecules for modulation of gene expression
03/30/2000WO2000017343A1 Method for making insertional mutations
03/30/2000WO2000017342A2 Intron-mediated recombinant techniques and reagents
03/30/2000WO2000017340A1 Process for producing poly-3-hydroxyalkanoic acid
03/30/2000WO2000017338A1 Upa/rag-2 mouse with mammalian repopulating hepatocytes for infection by hepadnaviruses
03/30/2000WO2000017337A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
03/30/2000WO2000017336A1 Dna cassette encoding a multimer of a biologically active peptide and a cleavable linker attached thereto and process for preparing the biologically active peptide
03/30/2000WO2000017335A1 IMMOBILIZED cDNA LIBRARIES
03/30/2000WO2000017334A2 Analysis of ligand activated nuclear receptors i(in vivo)
03/30/2000WO2000017331A1 A 2,6-β-D-FRUCTAN HYDROLASE ENZYME AND PROCESSES FOR USING THE ENZYME
03/30/2000WO2000017330A1 Dna polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides
03/30/2000WO2000017329A1 Rec2 kinase
03/30/2000WO2000017327A2 Terpene synthases
03/30/2000WO2000017324A1 High-induction alpha-amylase gene promoters
03/30/2000WO2000017323A1 Stable neural stem cell lines
03/30/2000WO2000017321A2 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering
03/30/2000WO2000017319A2 Synthesis of vanillin from a carbon source
03/30/2000WO2000017240A1 Hmw endostatin for inhibiting the growth of tumours and capillary proliferation and for diagnosing vascular and tumour diseases
03/30/2000WO2000017238A1 Protein having cell proliferation promoting effect
03/30/2000WO2000017237A1 Cerebral organic anion transporter and its gene
03/30/2000WO2000017235A2 Cytokine receptor zalpha11
03/30/2000WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000WO2000017232A2 Regulatory protein from human keratinocytes
03/30/2000WO2000017224A1 ANTISENSE MODULATION OF RhoC EXPRESSION
03/30/2000WO2000017223A1 ANTISENSE MODULATION OF RhoA EXPRESSION
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017221A1 Method of measuring protein-protein interactions in living cells
03/30/2000WO2000017220A1 Antisense modulation of fan expression
03/30/2000WO2000017219A1 Detection of human herpes virus 6 (hhv6)
03/30/2000WO2000017215A1 Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection
03/30/2000WO2000017103A2 Inventory control
03/30/2000WO2000016809A1 ANTISENSE MODULATION OF RhoB EXPRESSION
03/30/2000WO2000016807A1 Cationic compounds and their use as macro molecular carriers
03/30/2000WO2000016805A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
03/30/2000WO2000016746A2 Immunogenic liposome compositions
03/30/2000WO2000016631A1 Murf2
03/30/2000WO2000016609A1 Novel method of regulating seed development in plants and genetic sequences therefor
03/30/2000WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
03/30/2000WO2000008196A3 Urate oxidase
03/30/2000WO2000003026A3 Transcription coactivators
03/30/2000WO2000000614A9 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI)
03/30/2000WO2000000609A3 Molecules associated with apoptosis
03/30/2000WO1999067427A9 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
03/30/2000WO1999067393A3 Aav scleroprotein, production and use thereof
03/30/2000WO1999067358A3 Method of preparing objects containing dna
03/30/2000WO1999066959A9 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival
03/30/2000WO1999064593A3 Cell cycle regulation proteins
03/30/2000WO1999061608A3 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
03/30/2000WO1999061601A9 Aav5 vector and uses thereof
03/30/2000WO1999061597A3 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter
03/30/2000WO1999061066A9 Convection-enhanced delivery of aav vectors
03/30/2000WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof
03/30/2000WO1999058687A3 Bacillus thuringiensis toxins and genes for controlling coleopteran pests
03/30/2000WO1999057565A3 Methods for diagnosing and evaluating cancer
03/30/2000WO1999057311A3 Novel method for the identification of clones conferring a desired biological property from an expression library
03/30/2000WO1999057287A3 Beta-glucosidase coding sequences and protein from orpinomyces pc-2
03/30/2000WO1999057285A3 Sucrose phosphate synthase
03/30/2000WO1999057281A3 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same
03/30/2000WO1999055913A9 Reduced complexity nucleic acid targets and methods of using same
03/30/2000WO1999055831A3 Adenoviral vectors for treating disease
03/30/2000WO1999054470A3 Bacterial ygjd polypeptide family
03/30/2000WO1999053055A3 Therapeutic agent for ngf
03/30/2000WO1999051744A3 A interleukin-1 receptor antagonist and uses thereof
03/30/2000WO1999049892A3 Use of active p40 conjugates for nasal delivery
03/30/2000WO1999049047A3 Plant 1,3-beta-d-glucan synthase and brittle-1 encoding sequences
03/30/2000WO1999042477A3 Transporter protein for saccharide-coupled medicaments
03/30/2000WO1999041974A9 Methods for improving seeds
03/30/2000WO1999038980A3 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000DE19856261C1 Detection of gamma-secretase by detection of A-beta peptide useful for determining gamma-secretase activity and for identifying inhibitors
03/30/2000CA2689373A1 G protein-coupled receptor antagonists
03/30/2000CA2347129A1 Methods for large-scale production of recombinant aav vectors
03/30/2000CA2345392A1 Method of measuring protein-protein interactions in living cells
03/30/2000CA2345088A1 Gpr10 as a target for identifying weight modulating compounds
03/30/2000CA2344699A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
03/30/2000CA2344674A1 Plants capable of metabolizing chemical substances and use thereof
03/30/2000CA2344665A1 Synthesis of vanillin from a carbon source
1 ... 3265 3266 3267 3268 3269 3270 3271 3272 3273 3274 3275 3276 3277 3278 3279 3280 3281 3282 3283 3284 3285 ... 4023